Iria
Vázquez Urio
Investigadora hasta 2023
Clínica Universitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (5)
2020
-
Assessment of minimal residual disease by next generation sequencing in peripheral blood as a complementary tool for personalized transplant monitoring in myeloid neoplasms
Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-20
2006
-
ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia
Oncogene, Vol. 25, Núm. 13, pp. 1862-1870
-
Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia
International Journal of Cancer, Vol. 118, Núm. 8, pp. 1945-1953
-
Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter
British Journal of Haematology, Vol. 134, Núm. 2, pp. 137-144
2005
-
Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib
Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 22-26